Iqvia Holdings Inc.

Equities

IQV

US46266C1053

Market Closed - Nyse Other stock markets 21:00:02 10/04/2026 BST			5-day change	1st Jan Change
167.34 ^USD	-0.97%		-3.42%	-25.76%

04-09	Glenmark Pharmaceuticals Limited Receives U.S. FDA Approval for Progesterone Vaginal Inserts, 100 Mg	CI
04-09	Glenmark Pharma Gets US FDA Final Nod for Progesterone Vaginal Inserts	MT

Transcript : IQVIA Holdings Inc. - Special Call

Published on 04/28/2025 - Modified on 06/23/2025 at 08:21 pm BST

S&P Capital IQ

Presenter Speech
Todd Culpepper (Executives)

Welcome to today's webinar on Pathways to Overcome Challenges to CAR T-cell Therapy Health System Readiness. I'm Todd Culpepper with the IQVIA Institute,

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Latest news about Iqvia Holdings Inc.

04-09	Glenmark Pharmaceuticals Limited Receives U.S. FDA Approval for Progesterone Vaginal Inserts, 100 Mg	CI
04-09	Glenmark Pharma Gets US FDA Final Nod for Progesterone Vaginal Inserts	MT
04-08	Evercore ISI Adjusts Price Target on IQVIA Holdings to $185 From $225, Maintains Outperform Rating	MT
04-08	Baird Adjusts Price Target on IQVIA Holdings to $230 From $243, Maintains Outperform Rating	MT
03-31	AI-led selloff in contract research firms may be misjudging disruption risk	RE
03-31	Shield Therapeutics plc Announces European Medicines Agency Approves Extension of Indication for FeRACCRU to Include Adolescents	CI
03-30	Cipla Limited Announces Appointment of Senior Management Personnel of the Company Effective 1 April, 2026	CI
03-30	Jefferies Adjusts Price Target on IQVIA Holdings to $220 From $255, Maintains Buy Rating	MT
03-23	Royalty Pharma plc Appoints Lucas Glass as Head of Artificial Intelligence, Effective April 2026	CI
03-20	Aquestive Therapeutics, Inc. Announces Executive Changes, Effective April 2, 2026	CI
03-20	Shanghai Henlius Biotech, Inc. Announces Approval Of Investigational New Drug Application For Phase 1 Clinical Trial Of Nivolumab Biosimilar HLX18	CI
03-16	IQVIA unveils IQVIA.AI, a unified agentic AI platform powered by Nvidia to improve efficiency and decision making across life sciences	RE
03-16	IQVIA Holdings Inc And NVIDIA Launch Unified Agentic AI Platform IQVIA.ai	CI
03-16	NVIDIA Corporation Announces Open Agent Development Platform And Agent Toolkit	CI
03-16	Glenmark Pharmaceuticals to Launch Potassium Phosphates Injection in March	MT